Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV
Open Access
- 30 December 2021
- journal article
- research article
- Published by Elsevier in Cell Reports Medicine
- Vol. 3 (1) , 100487
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Wellcome Trust (204797/Z/16/Z, 206194, 206508/Z/17/Z)
This publication has 62 references indexed in Scilit:
- Arginase Activity - A Marker of Disease Status in Patients with Visceral Leishmaniasis in EthiopiaPLOS Neglected Tropical Diseases, 2013
- Arginase Activity in the Blood of Patients with Visceral Leishmaniasis and HIV InfectionPLOS Neglected Tropical Diseases, 2013
- Immunobiology of visceral leishmaniasisFrontiers in Immunology, 2012
- IL-10 Neutralization Promotes Parasite Clearance in Splenic Aspirate Cells From Patients With Visceral LeishmaniasisThe Journal of Infectious Diseases, 2011
- Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune responseNature Reviews Immunology, 2011
- Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic ReviewPLOS Neglected Tropical Diseases, 2011
- High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral loadBMC Infectious Diseases, 2010
- Hematologic Changes in Visceral Leishmaniasis/Kala AzarIndian Journal of Hematology and Blood Transfusion, 2010
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Malnutrition and Infection: Complex Mechanisms and Global ImpactsPLOS Medicine, 2007